01/01/2020 12:00 AM EST
Source: Access to Medicine Foundation. Published: 1/2020. This 208-page report has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. It evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to limit antimicrobial resistance, such as R&D, managing manufacturing waste, and ensuring appropriate access and stewardship. (PDF)
.png)
No hay comentarios:
Publicar un comentario